Patents by Inventor Gerold L. Mosher

Gerold L. Mosher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918685
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Grant
    Filed: May 30, 2023
    Date of Patent: March 5, 2024
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Scott Brauer, Gerold L. Mosher
  • Publication number: 20230405079
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Application
    Filed: August 16, 2023
    Publication date: December 21, 2023
    Inventors: Gerold L. MOSHER, David W. MILES
  • Publication number: 20230338287
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Application
    Filed: May 30, 2023
    Publication date: October 26, 2023
    Inventors: Scott BRAUER, Gerold L. Mosher
  • Patent number: 11771733
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: October 3, 2023
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Patent number: 11701326
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: July 18, 2023
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Scott Brauer, Gerold L. Mosher
  • Publication number: 20220401363
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Application
    Filed: August 22, 2022
    Publication date: December 22, 2022
    Inventors: Scott BRAUER, Gerold L. MOSHER
  • Patent number: 11484498
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: November 1, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Scott Brauer, Gerold L. Mosher
  • Patent number: 11471409
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: October 18, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Scott Brauer, Gerold L. Mosher
  • Patent number: 11464862
    Abstract: An inhalable dry powder formulation containing SAE-CD and an active agent is provided. The formulation is adapted for administration by DPI. The SAE-CD serves as a carrier rather than as an absorption enhancer. The average particle size of the SAE-CD is large enough to preclude (for the most part) pulmonary deposition thereof. Following release from the DPI device, the SAE-CD-containing particles dissociate from the active agent-containing particles in the buccal cavity or throat, after which the active agent-containing particles continue deeper into the respiratory tract. The physicochemical and morphological properties of the SAE-CD are easily modified to permit optimization of active agent and carrier interactions. Drugs having a positive, neutral or negative electrostatic charge can be delivered by DPI when SAE-CD is used as a carrier.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: October 11, 2022
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventors: James D. Pipkin, Gerold L. Mosher, Douglas B. Hecker
  • Publication number: 20220296578
    Abstract: Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Application
    Filed: April 8, 2022
    Publication date: September 22, 2022
    Inventors: Scott BRAUER, Gerold L. MOSHER
  • Patent number: 11364230
    Abstract: Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: June 21, 2022
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Scott Brauer, Gerold L. Mosher
  • Publication number: 20220111000
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Application
    Filed: October 21, 2021
    Publication date: April 14, 2022
    Inventors: Gerold L. MOSHER, David W. MILES
  • Publication number: 20220096664
    Abstract: The invention encompasses compositions containing an iodinated contrast agent and a substituted cyclodextrin wherein the cyclodextrin stabilizes the contrast agent against degradation by ultraviolet or visible light exposure.
    Type: Application
    Filed: July 7, 2021
    Publication date: March 31, 2022
    Inventor: Gerold L. Mosher
  • Publication number: 20220047549
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Inventors: Gerold L. MOSHER, David W. MILES
  • Patent number: 11179434
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: November 23, 2021
    Assignee: Silvergate Pharmaceuticals Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Patent number: 11173141
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: November 16, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Patent number: 11141405
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 12, 2021
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Publication number: 20210308049
    Abstract: Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
    Type: Application
    Filed: June 11, 2021
    Publication date: October 7, 2021
    Inventors: Scott Brauer, Gerold L. Mosher
  • Publication number: 20210299092
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 30, 2021
    Inventors: Gerold L. Mosher, David W. Miles
  • Publication number: 20210251956
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: April 12, 2021
    Publication date: August 19, 2021
    Inventors: Gerold L. Mosher, David W. Miles